Nuvalent, Inc. (NUVL) Financial Statements (2024 and earlier)

Company Profile

Business Address ONE BROADWAY, 14TH FLOOR
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments431,239,000450,462,000472,163,000240,064,000256,964,000272,734,000
Cash and cash equivalents70,872,00090,115,000241,806,00076,313,00075,915,00067,273,000
Short-term investments360,367,000360,347,000230,357,000163,751,000181,049,000205,461,000
Other undisclosed current assets5,753,0005,831,0005,828,0005,181,0001,858,0001,739,000
Total current assets:436,992,000456,293,000477,991,000245,245,000258,822,000274,473,000
Noncurrent Assets
Other noncurrent assets4,956,0004,696,0004,468,0004,313,0004,199,0002,566,000
Total noncurrent assets:4,956,0004,696,0004,468,0004,313,0004,199,0002,566,000
TOTAL ASSETS:441,948,000460,989,000482,459,000249,558,000263,021,000277,039,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities20,795,00017,021,00019,481,00015,992,00012,076,0008,124,000
Employee-related liabilities3,017,0002,040,000
Accounts payable8,117,0006,433,0007,195,0004,620,0004,028,0004,246,000
Accrued liabilities12,678,00010,588,00012,286,0008,355,0006,008,0003,878,000
Other undisclosed current liabilities    (3,017,000)(2,040,000) 
Total current liabilities:20,795,00017,021,00019,481,00012,975,00010,036,0008,124,000
Noncurrent Liabilities
Total liabilities:20,795,00017,021,00019,481,00012,975,00010,036,0008,124,000
Equity
Equity, attributable to parent, including:421,153,000443,968,000462,978,000236,583,000252,985,000268,915,000
Additional paid in capital637,043,000629,533,000623,543,000371,398,000368,350,000365,701,000
Accumulated other comprehensive loss(1,537,000)(302,000)(494,000)(866,000)(1,132,000)(1,019,000)
Accumulated deficit(214,359,000)(185,269,000)(160,077,000)(133,954,000)(114,238,000)(95,772,000)
Other undisclosed equity, attributable to parent6,0006,0006,0005,0005,0005,000
Total equity:421,153,000443,968,000462,978,000236,583,000252,985,000268,915,000
TOTAL LIABILITIES AND EQUITY:441,948,000460,989,000482,459,000249,558,000263,021,000277,039,000

Income Statement (P&L) (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Operating expenses(34,062,000)(30,210,000)(29,299,000)(20,388,000)(18,733,000)(17,688,000)
Operating loss:(34,062,000)(30,210,000)(29,299,000)(20,388,000)(18,733,000)(17,688,000)
Nonoperating income4,972,0005,018,0003,176,000672,000267,000139,000
Other nonoperating income    672,000267,000139,000
Loss from continuing operations:(29,090,000)(25,192,000)(26,123,000)(19,716,000)(18,466,000)(17,549,000)
Loss before gain (loss) on sale of properties:(19,716,000)(18,466,000)(17,549,000)
Net loss available to common stockholders, diluted:(29,090,000)(25,192,000)(26,123,000)(19,716,000)(18,466,000)(17,549,000)

Comprehensive Income (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(29,090,000)(25,192,000)(26,123,000)(19,716,000)(18,466,000)(17,549,000)
Comprehensive loss:(29,090,000)(25,192,000)(26,123,000)(19,716,000)(18,466,000)(17,549,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,235,000)192,000372,000266,000(113,000)(791,000)
Comprehensive loss, net of tax, attributable to parent:(30,325,000)(25,000,000)(25,751,000)(19,450,000)(18,579,000)(18,340,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: